Icrucumab
Product Specifications
CAS Number
1024603-92-6
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
>95%
Bioactivity
Icrucumab (IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1.Icrucumab has antitumor activity.Icrucumab has been studied in metastatic colon cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15239514 1 Vial
Lentiviral mouse Asphd2 shRNA (UAS) - Lentiviral mouse Asphd2 shRNA (UAS) (100)
Sign In for Pricing
View Details 